PlainRecalls
FDA Drug Low Class III Terminated

Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle, Rx only, Finished product manufactured by: Janssen Ortho, LLC, Gurabo PR 00778, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, NJ 08560, NDC 50458-543-60

Reported: November 2, 2016 Initiated: October 19, 2016 #D-0115-2017

Product Description

Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle, Rx only, Finished product manufactured by: Janssen Ortho, LLC, Gurabo PR 00778, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, NJ 08560, NDC 50458-543-60

Reason for Recall

Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.

Details

Recalling Firm
Janssen Ortho L.L.C.
Units Affected
5346 bottles
Distribution
Nationwide and Puerto Rico
Location
Gurabo, PR

Frequently Asked Questions

What product was recalled?
Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle, Rx only, Finished product manufactured by: Janssen Ortho, LLC, Gurabo PR 00778, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, NJ 08560, NDC 50458-543-60. Recalled by Janssen Ortho L.L.C.. Units affected: 5346 bottles.
Why was this product recalled?
Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 2, 2016. Severity: Low. Recall number: D-0115-2017.